List of Studies ( Metabolite:Pregnenolone sulfate)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST001192 | AN001986 | A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research | Feces | Human | The Broad Institute | Abundance | |
ST002247 | AN003673 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | Abundances | |
ST003066 | AN005022 | Heritability of RBC metabolites: baseline correlation of metabolites and markers of RBC health and stability | Erythrocytes | Human | University of Iowa | area under curve | |
ST001639 | AN002683 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | AU |
ST002391 | AN003896 | Evaluation of Two Simultaneous Metabolomic and Proteomic Extraction Protocols Assessed by Ultra-High-Performance Liq-uid Chromatography Tandem Mass Spectrometry | Blood | Human | Sharjah Institute for Medical Research | AU | |
ST002730 | AN004427 | Multi-Omics profiling of Candida albicans from agar plate and suspension media | Yeast cells | Candida albicans | University of Sharjah | AU | |
ST002976 | AN004886 | Metabolomics Insights into Doxorubicin and 5-Fluorouracil Combination Therapy in Triple-Negative Breast Cancer: A Xenograft Model Study (Part 2) | Blood | Mouse | Cancer | Sharjah Institute for Medical Research | AU |
ST003029 | AN004966 | Estrogen-mediated inhibition of purine metabolism and cell cycle arrest as a novel therapeutic approach in colorectal cancer cells | Colorectal Cancer Cells | Human | Cancer | Sharjah Institute for Medical Research | AU |
ST000042 | AN000065 | BALF Control vs ALI by RPLC-MS | Lung | Human | University of Michigan | Counts | |
ST000044 | AN000069 | Pilot experiment looking for the existence of certain molecules in pancreatic cancer cells | Pancreas | Human | Cancer | University of Michigan | Counts |
ST000090 | AN000144 | Caloric Restriction vs drugs | Blood | Mouse | University of Michigan | Counts | |
ST000105 | AN000174 | SCOR Metabolomics | Blood | Human | University of Chicago | Counts | |
ST000106 | AN000176 | IWMS Study 1:Weight comparison of obese and lean patients | Blood | Human | Obesity | University of Michigan | Counts |
ST002869 | AN004703 | Identifying Biodegradation Pathways of Cetrimonium Bromide (CTAB) Using Metagenome, Metatranscriptome, and Metabolome Tri-omics Integration | Water | Bacteria | Environmental exposure | Arizona State University | counts per second |
ST001402 | AN002344 | Ontogeny related changes in the pediatric liver metabolome | Liver | Human | Moffitt Cancer Center | estimated abundances | |
ST001403 | AN002345 | Ontogeny related changes in the pediatric liver metabolome (part-II) | Liver | Human | Moffitt Cancer Center | estimated abundances | |
ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham Women's Hospital | intensity |
ST002244 | AN003664 | Metabolomics analysis of Friedreich's ataxia (FRDA) (part I) | Blood | Human | Friedreichs Ataxia | University of Pennsylvania | intensity |
ST003291 | AN005390 | Atopic dermatitis and STAT3 double null mutant skin biopsies during healing. | Skin | Human | Eczema | National Institutes of Health | Intensity |
ST002459 | AN004012 | Comparison of metabolite profiles from matched whole blood microsamplers, whole blood dried blood spots, and plasma. | Blood | Human | Icahn School of Medicine at Mount Sinai | Ion abundance | |
ST002829 | AN004621 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Blood | Human | COVID-19 | National Institutes of Health | log transformed data |
ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST003312 | AN005424 | Integrative analysis of serum and fecal metabolome and the microbiome that herald Crohn Disease flare - serum | Blood | Human | Inflammatory bowel disease; Crohn disease | Sheba hospital | normalized metabolite percentage per sample |
ST001789 | AN002901 | Acute metabolomic changes of plasma in response to endurance exercise | Blood | Human | University of California, San Diego | peak area | |
ST002498 | AN004656 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | peak area |
ST003044 | AN004993 | A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics | Blood | Human | Obesity | University of Colorado Denver | peak area |
ST000009 | AN000024 | Mixed meal tolerance | Human | University of Michigan | Peak area | ||
ST000010 | AN000026 | Lung Cancer Cells 4 | Lung | Human | Cancer | University of Michigan | Peak area |
ST000011 | AN000028 | African Metabolomics | Human | University of Michigan | Peak area | ||
ST000017 | AN000035 | Rat HCR/LCR Stamina Study | Blood | Rat | University of Michigan | Peak area | |
ST001212 | AN002046 | Fish-oil supplementation in pregnancy, child metabolomics and asthma risk | Blood | Human | Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen | Peak area | |
ST001385 | AN002312 | Urine Metabolomics | Urine | Human | Icahn School of Medicine at Mount Sinai | Peak area | |
ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | Peak area |
ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | Peak area |
ST002977 | AN004890 | Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant | Feces | Human | University of Michigan | Peak area | |
ST003348 | AN005484 | An integrated LC-MS analysis of the biometric characteristics of different time cohorts of race walkers - untargeted | Blood | Human | The First Affiliated Hospital of Dalian Medical University | Peak area | |
ST003520 | AN005780 | Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | Peak area |
ST002909 | AN004777 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Peak Area |
ST001383 | AN002307 | Investigating exposures and health impacts of endocrine disrupting chemicals among inner-city children. | Blood | Human | Environmental exposure | University of Michigan | Peak area normalized |
ST000356 | AN000583 | GC/MS and LC/MS metabolomics profiling for breast cancer serum data and control serum data | Blood | Human | Cancer | University of Hawaii Cancer Center | Peak intensity |
ST000421 | AN000664 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000668 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000422 | AN000670 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
ST000566 | AN000869 | Large Scale C18 Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | Peak intensity |
ST000567 | AN000871 | Large Scale HILIC Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function | Blood | Human | Heart disease | Mayo Clinic | Peak intensity |
ST001048 | AN001717 | Pediatric Inner-City Environmental Exposures at School and Home and Asthma Study | Urine | Human | Asthma | Icahn School of Medicine at Mount Sinai | Peak intensity |
ST001317 | AN002193 | Dynamics of Exposure, Phthalates, and Asthma in a Randomized Trial (DEPART) | Urine | Human | Asthma | Icahn School of Medicine at Mount Sinai | Peak intensity |
ST001317 | AN002193 | Dynamics of Exposure, Phthalates, and Asthma in a Randomized Trial (DEPART) | Urine | Human | Environmental exposure | Icahn School of Medicine at Mount Sinai | Peak intensity |
ST001827 | AN002963 | The pregnancy metabolome from a multi-ethnic pregnancy cohort | Blood | Human | Icahn School of Medicine at Mount Sinai | pmoles/l | |
ST001835 | AN002977 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Blood | Human | Idaho Veterans Research and Education Foundation | raw area count | |
ST000899 | AN001464 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | raw area counts |
ST001400 | AN002341 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Blood | Human | Malaria | New York University Abu Dhabi | raw area counts |
ST001516 | AN002516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Blood | Human | Malaria | New York University Abu Dhabi | raw area counts |
ST001517 | AN002519 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Blood | Human | Malaria | New York University Abu Dhabi | raw area counts |
ST001749 | AN002850 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin - Madison | Raw area counts |
ST002818 | AN004588 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002819 | AN004592 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002820 | AN004596 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST000046 | AN000079 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST001404 | AN002346 | Ontogeny related changes in the pediatric liver metabolome (part-III) | Liver | Human | Moffitt Cancer Center | Relative Abundance | |
ST002088 | AN003408 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST002089 | AN003412 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | scaled imputed | |
ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST000974 | AN001595 | GC6-74 matabolomic of TB (Part 1: Plasma) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | scaled units |
ST000975 | AN001596 | GC6-74 metabolomics of TB vs healthy (Part 2: Serum) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | scaled units |
ST000976 | AN001597 | GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | scaled units |
ST001515 | AN002513 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Blood | Human | Obesity | Translational Research Institute- AdventHealth Orlando | scaled units |
ST003161 | AN005186 | Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort | Feces | Human | Inflammatory bowel disease | Sheba hospital | TSS normalized values |
ST002246 | AN003669 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | Unitless Abundances | |
ST001519 | AN002528 | Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) | Feces | Human | Broad Institute of MIT and Harvard | unitless peak areas | |
ST001521 | AN002536 | Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) | Blood | Human | Broad Institute of MIT and Harvard | unitless peak areas |